Acutaas Chemicals · NSE: ACUTAAS · BSE: 543349
Q2 FY24 results · Jul–Sep 2023
Acutaas Chemicals reported revenue from operations of ₹172.36 crore (up 17.3% from Q2 FY23) and net loss of ₹17.02 crore for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 172.36 | 146.99 | +17.3% | 142.35 | +21.1% |
| Other income | 1.50 | 0.85 | +75.8% | 1.10 | +36.3% |
| Total income | 173.86 | 147.84 | +17.6% | 143.45 | +21.2% |
| Profit before tax | (9.94) | 25.71 | Turned loss | 22.32 | Turned loss |
| Net profit for the period | (17.02) | 19.04 | Turned loss | 16.65 | Turned loss |
| Attributable to shareholders of the company | (18.85) | — | — | — | — |
| EPS, basic (₹) | (4.67) | 5.50 | Turned loss | 4.57 | Turned loss |
| Net margin (%) | -9.9 | 13.0 | 11.7 |
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 163.60 | 146.99 | +11.3% | 142.35 | +14.9% |
| Other income | 1.26 | 0.85 | +47.4% | 1.10 | +14.3% |
| Total income | 164.86 | 147.84 | +11.5% | 143.45 | +14.9% |
| Profit before tax | (16.05) | 25.71 | Turned loss | 22.53 | Turned loss |
| Net profit for the period | (20.96) | 19.04 | Turned loss | 16.86 | Turned loss |
| EPS, basic (₹) | (5.75) | 5.18 | Turned loss | 4.63 | Turned loss |
| Net margin (%) | -12.8 | 13.0 | 11.8 |
Consolidated
- Filed with BSE
- 13 Nov 2023, 13:24 IST
- Board meeting
- 08 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Nov 2023, 13:24 IST
- Board meeting
- 08 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE